Implementation and pharmacoeconomic analysis of a clinical staff pharmacist practice model

American Journal of Health-System Pharmacy

Volumn 58, Issue 9, 2001, Pages 784-790

  Nesbit, T W ^a   Shermock, K M ^a   Bobek, M B ^a   Capozzi, D L ^a   Flores, P A ^a   Leonard, M C ^a   Long, J K ^a   Militello, M A ^a   White, D A ^a   Barone, L D ^a   Goldman, M P ^a   Kvancz, D A ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Administration; Clinical pharmacists; Clinical pharmacy; Costs; Economics; Hospital; Institutional; Interventions; Pharmaceutical services; Pharmacy

Indexed keywords

DRUG;

ARTICLE; CLINICAL PHARMACY; CLINICAL PRACTICE; COST BENEFIT ANALYSIS; COST CONTROL; COST MINIMIZATION ANALYSIS; ECONOMICS; HUMAN; MODEL; MONEY; NORMAL HUMAN; PHARMACIST; PHARMACY; PRIORITY JOURNAL; SIDE EFFECT; TEACHER; UNIVERSITY HOSPITAL;

EID: 0035337015     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/58.9.784     Document Type: Article

References (24)

1. Drug-related morbidity and mortality: A cost-of-illness model
2. Adverse drug events in hospitalized patients: Excess length of stay, extra costs, and attributable mortality
3. The costs of adverse drug events in hospitalized patients
4. Incidence of adverse drug events and potential adverse drug events: Implications for prevention
5. Incidence of adverse drug reactions in hospitalized patients: A meta-analysis of prospective studies
6. Health spending in 1998: Signals of change
7. Prescription drug sales expected to climb 43% in the US by 2002
8. Economic evaluations of clinical pharmacy services - 1988-1995
9. Clinical pharmacy services and hospital mortality rates
10. Health care professional staffing, hospital characteristics, and hospital mortality rates
11. Clinical pharmacy services, pharmacist staffing, and drug costs in United States hospitals
12. Clinical pharmacy services, pharmacy staffing, and the total cost of care in United States hospitals
13. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit
14. Effect of pharmacists on health care outcomes in hospitalized patients
15. Pharmacist influence on economic and morbidity outcomes in a tertiary care teaching hospital
16. A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy
17. Early switch to oral antibiotics: Guidelines and implementation in a large teaching hospital
18. Cost savings and avoidance from clinical interventions
19. A prospective, randomized trial to assess the cost impact of pharmacist-initiated interventions
20. Economic impact of a drug information service
21. Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team
22. Pharmacists and the quality-of-care imperative
23. The costs of adverse drug events in hospitalized patients